WAVE LIFE SCIENCES LTD. 2023-2024 Proxy Voting Records

Description as filed by funds: The Election of the Nominees for Director: Adrian Rawcliffe

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Adrian Rawcliffe”): 79,355,208 for, 30,812 against, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 14 asset managers below reported 6,607,235 for.

Description as filed by funds: The Election of the Nominees for Director: Aik Na Tan

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Aik Na Tan”): 72,527,209 for, 6,859,682 against, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 14 asset managers below reported 6,607,235 for.

Description as filed by funds: The Election of the Nominees for Director: Christian Henry

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Christian Henry”): 76,349,909 for, 3,034,581 against, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 14 asset managers below reported 5,051,789 for, 1,555,446 against.

Description as filed by funds: The Election of the Nominees for Director: Gregory L. Verdine, Ph.D.

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Gregory L. Verdine, Ph.D.”): 72,514,705 for, 6,874,231 against, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 14 asset managers below reported 6,607,235 for.

Description as filed by funds: The Election of the Nominees for Director: Heidi L. Wagner, J.D.

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Heidi L. Wagner, J.D.”): 79,014,026 for, 372,880 against, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.5% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 14 asset managers below reported 6,525,280 for, 81,955 against.

Description as filed by funds: The Election of the Nominees for Director: Ken Takanashi

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Ken Takanashi”): 70,139,009 for, 9,249,372 against, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 14 asset managers below reported 5,942,257 for, 664,978 against.

Description as filed by funds: The Election of the Nominees for Director: Mark H. N. Corrigan, M.D.

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Mark H.N. Corrigan, M.D.”): 79,316,599 for, 71,046 against, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 14 asset managers below reported 6,607,235 for.

Description as filed by funds: The Election of the Nominees for Director: Paul B. Bolno, M.D., MBA

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Paul B. Bolno, M.D., MBA”): 79,250,899 for, 134,322 against, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 14 asset managers below reported 6,607,235 for.

Description as filed by funds: The Election of the Nominees for Director: Peter Kolchinsky, Ph.D.

WAVE LIFE SCIENCES LTD.’s own tally for this item (“Elect Director: Peter Kolchinsky, Ph.D.”): 79,256,652 for, 128,404 against, per its Form 8-K filed August 7, 2023 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 14 asset managers below reported 6,607,235 for.

Description as filed by funds: To authorize the Board of Directors to allot and issue Ordinary Shares of Wave Life Sciences Ltd.

WAVE LIFE SCIENCES LTD.’s own tally for this item (“6. A general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast”): 66,559,346 for, 12,815,255 against — passed, per its Form 8-K filed August 7, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 6 - Shareholders approved a general authorization for the directors of the Company to allot and issue ordinary shares of the Company, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follows:”
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 13 managers: 5,184,790 for, 1,416,295 against.

Institutional-manager reports, all 2 managers: 6,150 against, 3,915,778 withheld.

Description as filed by funds: To approve the Company's payment of cash and equity-based compensation to non-employee directors for service on the Board of Directors and its committees, in the manner and on the basis set forth under "Proposal 3: Non- Employee Directors' Compensation" in the proxy statement

WAVE LIFE SCIENCES LTD.’s own tally for this item (“3. The Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on the Board of Directors and its committees, in the manner and on the basis set forth in the Proxy”): 79,308,018 for, 68,746 against — passed, per its Form 8-K filed August 7, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 - Shareholders approved the Company's payment of cash and equity-based compensation to the Company's non-employee directors for their service on the Board of Directors and its committees, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follow…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 13 managers: 6,601,085 for.

Institutional-manager reports, all 2 managers: 6,150 for, 3,915,778 withheld.

Description as filed by funds: To approve a proposed amendment to the Company's 2019 Employee Share Purchase Plan in the manner and on the basis as set forth under "Proposal 5: Approval of an Amendment to the 2019 Employee Share Purchase Plan" in the proxy statement

WAVE LIFE SCIENCES LTD.’s own tally for this item (“5. The amendment to the Company's 2019 Employee Share Purchase Plan, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast”): 79,345,186 for, 38,012 against — passed, per its Form 8-K filed August 7, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 5 - Shareholders approved the amendment to the Company's 2019 Employee Share Purchase Plan, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follows:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 13 managers: 6,601,085 for.

Institutional-manager reports, all 2 managers: 6,150 for, 3,915,778 withheld.

Description as filed by funds: To approve a proposed amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis as set forth under "Proposal 4: Approval of an Amendment to the 2021 Equity Incentive Plan, as amended" in the proxy statement

WAVE LIFE SCIENCES LTD.’s own tally for this item (“4. The amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast”): 78,539,704 for, 835,472 against — passed, per its Form 8-K filed August 7, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 4 - Shareholders approved the amendment to the Company's 2021 Equity Incentive Plan, as amended, in the manner and on the basis set forth in the Proxy Statement, with the final votes cast as follows:”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 13 managers: 5,914,817 for, 686,268 against.

Institutional-manager reports, all 2 managers: 6,150 for, 3,915,778 withheld.

Description as filed by funds: To approve, by a non-binding advisory vote, the compensation of our named executive officers as disclosed in the proxy statement

WAVE LIFE SCIENCES LTD.’s own tally for this item (“7. On a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on the basis set forth described in the Proxy Statement, with the final votes cast”): 79,211,157 for, 150,975 against — passed, per its Form 8-K filed August 7, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 7 - Shareholders approved on a non-binding, advisory basis only, the compensation of the Company's named executive officers, in the manner and on the basis set forth described in the Proxy Statement, with the final votes cast as follows:”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports, all 13 managers: 6,599,224 for, 1,861 against.

Institutional-manager reports, all 49 managers: 50,759,022 for, 11,861 against, 3,915,778 withheld, 632 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Description as filed by funds: To approve the re-appointment of KPMG LLP to serve as our independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2023, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuneration for services provided through the date of our 2024 Annual General Meeting of Shareholders

WAVE LIFE SCIENCES LTD.’s own tally for this item (“2. The re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2023, and to authorize the Audit Committee of t”): 83,495,478 for, 45,691 against — passed, per its Form 8-K filed August 7, 2023 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 - Shareholders approved the re-appointment of KPMG LLP to serve as the Company's independent registered public accounting firm and independent Singapore auditor for the year ending December 31, 2023, and to authorize the Audit Committee of the Board of Directors to fix KPMG LLP's remuner…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 14 asset managers below reported 6,607,235 for.